This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ryvu Therapeutics S.a.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Exploring the Contributions of Tushar Ravindra Mahajan in Patent Innovation
Introduction
Tushar Ravindra Mahajan is an esteemed inventor based in Cracow, Poland. He has made significant contributions to the field of therapeutic innovations, particularly with his work on modulators of the stimulator of interferon genes (STING). His research and invention hold promise for the advancement of medical treatments.
Latest Patents
Mahajan has been awarded a patent for his invention titled "Modulators of Stimulator of Interferon Genes (STING)." This patent encompasses compounds that are beneficial as modulators of STING, and it includes various forms such as salts, stereoisomers, tautomers, or N-oxides. Not only are these compounds useful for scientific research, but they are also proposed for use as a medicament, further incorporated into pharmaceutical compositions.
Career Highlights
Tushar is associated with Ryvu Therapeutics S.A., a company dedicated to developing innovative therapies. His tenure at this firm highlights his commitment to advancing medical research and improving patient outcomes through innovative drug development.
Collaborations
During his professional journey, Mahajan has had the opportunity to collaborate with talented coworkers, including Monika Patrycja Dobrzanska and Magdalena Izabela Zawadzka. Their collective efforts contribute to the innovative work being conducted within Ryvu Therapeutics and the broader scientific community.
Conclusion
Tushar Ravindra Mahajan represents a dynamic force in the realm of invention and innovation in medical science. His patent for modulators of STING illustrates the potential of his work to pave the way for new therapeutic approaches. Through his career at Ryvu Therapeutics and collaborations with esteemed colleagues, Mahajan continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile